Today: 11 June 2026
Rocket Lab (RKLB) Stock After Hours Today, Dec. 23, 2025: Latest Price, News, Analyst Forecasts, and What to Know Before the Market Opens Dec. 24
23 December 2025
4 mins read

Rocket Lab (RKLB) Stock After Hours Today, Dec. 23, 2025: Latest Price, News, Analyst Forecasts, and What to Know Before the Market Opens Dec. 24

Rocket Lab Corporation (NASDAQ: RKLB) finished Tuesday’s session (December 23, 2025) near its recent highs after a volatile holiday-week day of trading — and the stock is slightly lower in after-hours trading as investors digest a rapid run-up fueled by fresh defense-contract headlines and a wave of bullish analyst updates.

Below is what’s moving Rocket Lab stock after the bell today (23.12.2025) and what matters most before U.S. markets open tomorrow (Wednesday, Dec. 24, 2025).


Rocket Lab stock price after hours: where RKLB stands tonight

Rocket Lab shares closed at $77.18 on Tuesday.

In the first stretch of extended trading, the stock slipped to about $76.37 on Google Finance (timestamped shortly after the close).

On Public’s after-hours feed, RKLB was $76.45 at 4:30 p.m. ET, down about 0.95% from the regular-session close, with after-hours trades ranging roughly $75.62 to $77.44.

Tuesday’s regular-session tape showed a wide day range ($73.29 to $79.18), highlighting just how jumpy trading has been as RKLB hovers near fresh highs.


Why Rocket Lab stock was so volatile today

1) Profit-taking risk is rising after a huge December surge

Rocket Lab has been one of the market’s standout momentum names this month. Barron’s reported RKLB was up about 84% in December as of today, reflecting a sharp re-pricing of its defense and launch outlook.

That kind of move can invite “fast money” profit-taking and whipsaw price action — especially in a holiday week when liquidity is thinner.

2) The Space Force/SDA win remains the headline catalyst

The biggest fundamental driver remains Rocket Lab’s newly announced prime contractor role on the Space Development Agency’s Tracking Layer Tranche 3 program.

Rocket Lab says it won an $816 million prime contract to design and manufacture 18 satellites, including a $806 million base plus up to $10.45 million in options.

The SDA’s own announcement described Rocket Lab’s award at about $805 million for 18 MWTD satellites.

While the exact figure varies by how the award and options are described, the market takeaway has been consistent: it’s Rocket Lab’s largest contract to date, and the company says the deal builds on an existing $515 million SDA award — bringing SDA-awarded value to Rocket Lab to more than $1.3 billion.

Why investors care: Rocket Lab emphasizes its ability to produce key components in-house (vertical integration) and notes additional “merchant supplier” opportunities that could push total program capture value toward ~$1 billion across payloads, solar, software, and other subsystems. Rocket Lab

3) Wall Street price targets jumped — and the market is reacting in real time

Today’s coverage was dominated by analyst upgrades following the SDA award.

  • Needham raised its Rocket Lab price target to $90 from $63, reiterating a Buy rating, citing the SDA award and Rocket Lab’s growing role in national security space.
  • Stifel lifted its price target to $85 from $75 while maintaining a Buy, according to reporting that cited TheFly.

At the same time, not every “forecast” is uniformly bullish. TipRanks’ consensus snapshot in today’s Needham write-up described RKLB as a Moderate Buy, but with an average price target of $68.25, implying potential downside versus current levels. TipRanks

Translation: optimism is high — but expectations are now high enough that “good news” may need to keep arriving to justify the premium.

4) Big-name fund flows and insider headlines are adding noise

Two additional developments were in today’s news cycle and may be contributing to short-term volatility:

  • Cathie Wood’s ARK disclosed trades showing a sale of 232,425 Rocket Lab shares worth about $16.39 million (from Monday’s trade blotter), per Investing.com.
  • Insider-selling headlines circulated via TradingView, including sales by directors Jon A. Olson (15,000 shares) and Merline Saintil (5,000 shares) dated Dec. 19, 2025, noted as executed under Rule 10b5-1 trading plans.

Neither item necessarily changes Rocket Lab’s long-term story on its own — but when a stock has surged this quickly, flow-related headlines can have an outsized impact on short-term price action.

5) A Washington tailwind is keeping “space” in focus

Another sector-wide catalyst: the White House posted an executive order titled “Ensuring American Space Superiority” (signed Dec. 18, 2025), which includes goals such as returning Americans to the Moon by 2028 via Artemis. The White House

The order was also published in the Federal Register with a publication date of Dec. 23, 2025 (today).

Even though this isn’t a Rocket Lab-specific contract award, it’s part of the broader narrative investors have been trading: accelerating U.S. emphasis on space security, procurement, and industrial capacity — themes that tend to lift interest across space and defense suppliers.


What to watch before the stock market opens tomorrow (Wednesday, Dec. 24, 2025)

1) Tomorrow is a shortened trading day (Christmas Eve)

U.S. markets are scheduled to close early at 1:00 p.m. ET on Wednesday, Dec. 24, 2025, per NYSE’s official hours calendar.

Why this matters for RKLB: shortened sessions often mean thinner liquidity, which can amplify price gaps and intraday swings — especially in high-beta names.

2) Keep an eye on the 8:30 a.m. ET data drop

Economic calendars flag initial jobless claims at 8:30 a.m. ET on Dec. 24.

For RKLB specifically, macro data usually isn’t the main driver day-to-day, but high-growth and high-momentum stocks can react sharply if rates or risk appetite move.

3) Watch whether after-hours softness turns into a premarket gap

Tonight’s after-hours dip is modest (roughly ~1% in early extended trading), but premarket can reset the tone quickly.

A useful way to frame tomorrow’s setup using today’s tape:

  • Support zone to watch: Today’s low around $73.29 (if selling accelerates).
  • Overhead reference: Today’s high near $79.18 (if momentum returns).

4) The “next catalysts” traders are likely to keep circling

While tonight is about after-hours positioning, the next visible milestones that keep showing up in recent coverage include:

  • Ongoing ramp and execution risk for the SDA Tracking Layer contract (large, complex, and time-phased).
  • Rocket Lab’s push to expand Electron missions in 2026 (including more iQPS launches planned from 2026 and a next Electron mission slated for early Q1 2026, per the company).
  • The industry’s focus on Rocket Lab’s medium-lift Neutron development timeline as a potential 2026 swing factor (frequently referenced alongside the defense backlog in today’s analyst coverage).

Bottom line for RKLB heading into tomorrow’s open

Rocket Lab stock is cooling slightly after hours after a wild intraday swing that still left shares near elevated levels — a classic setup when a stock has just repriced higher on blockbuster contract news and analyst upgrades.

For Wednesday morning (Dec. 24), the key is less about new headlines and more about how the market digests expectations: upgraded price targets on one side, profit-taking risk and “priced-for-perfection” concerns on the other — all in a shortened, holiday-thin session. TipRanks+2Barron’s+2

This article is for informational purposes only and is not investment advice.

Stock Market Today

  • Banco BPM Stock Valuation Reviewed as Shares Rise Amid Earnings Momentum
    June 11, 2026, 11:13 AM EDT. Banco BPM (BIT:BAMI) has posted robust share price gains of 8.85% in the past month and 51.01% over the last year, driven by strong earnings with revenue of €5.42 billion and net income of €2.05 billion. Despite recent appreciation, analysts see the stock as slightly overvalued at a consensus fair value of €13.71, below the current price of €14.03. Banco BPM trades at a price-to-earnings (P/E) ratio of 10.3 times, below European bank peers at 11.3 times, suggesting some valuation cushion. However, risks such as increased fintech competition and challenges in cost efficiencies remain. Investor focus is on whether current momentum fully reflects growth expectations or leaves room for further upside.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
XRP Price Today (05:03, Dec. 23, 2025): XRP Holds Near $1.88 as ETF Inflows Clash With Year‑End Selling
Previous Story

XRP Price Today (05:03, Dec. 23, 2025): XRP Holds Near $1.88 as ETF Inflows Clash With Year‑End Selling

IBM Stock After Hours Today (Dec. 23, 2025): Confluent Deal Filing, Late Trading Moves, and What to Watch Before the Market Opens Dec. 24
Next Story

IBM Stock After Hours Today (Dec. 23, 2025): Confluent Deal Filing, Late Trading Moves, and What to Watch Before the Market Opens Dec. 24

Go toTop